申请人:GlaxoSmithKline Intellectual Property Development
Limited
公开号:EP3530290A1
公开(公告)日:2019-08-28
Covalent conjugation of an alpha amino acid ester to a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by intracellular carboxylesterase enzyme hCE1 and not by hCE2 or hCE3 to the corresponding acid, leads to selective accumulation of the carboxylic acid hydrolysis product in monocyte/macrophage cell and enables improved or more prolonged enzyme or receptor modulation in those cells relative to the unconjugated modulator.
将α-氨基酸酯与细胞内目标酶或受体活性调节剂共价共轭,其中共轭物的酯基可被细胞内羧基酯酶hCE1水解为相应的酸,而不能被hCE2或hCE3水解为相应的酸、导致羧酸水解产物在单核细胞/巨噬细胞中选择性积累,与未共轭的调节剂相比,可改善或延长对这些细胞中酶或受体的调节。